Home Biosimilar Antibodies Others Others antibody Lirilumab (Anti-KIR) For research use only.
Not for use in humans.

Lirilumab (Anti-KIR)

Synonyms: IPH2102

Lirilumab (Anti-KIR) is a  fully human monoclonal antibody against killer-cell immunoglobulin-like receptors (KIR), with potential antineoplastic activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research. MW: 150 kD.

Lirilumab (Anti-KIR)

Purity & Quality Control

≥99

Biological Activity

Description Lirilumab (Anti-KIR) is a  fully human monoclonal antibody against killer-cell immunoglobulin-like receptors (KIR), with potential antineoplastic activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research. MW: 150 kD.

Product Details

CAS No. 1000676-41-4
Molecular Weight 150 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lirilumab (Anti-KIR) | Lirilumab (Anti-KIR) supplier | purchase Lirilumab (Anti-KIR) | Lirilumab (Anti-KIR) cost | Lirilumab (Anti-KIR) manufacturer | order Lirilumab (Anti-KIR) | Lirilumab (Anti-KIR) distributor